Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00956475 · ClinicalTrials.gov registry record
Quality of Life in Younger Leukemia and Lymphoma Survivors
A clinical trial, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- 48
- Enrollment target
NCT00956475: Completed study, sponsored by Case Comprehensive Cancer Center.
NCT00956475 is a clinical trial that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 48 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00956475 has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- 48 participants
- Enrollment target
Study Summary
RATIONALE: Collecting information about the effect of hematologic cancer and its treatment on quality of life may help doctors learn more about the disease and plan the best treatment. PURPOSE: This phase I trial is studying quality of life in younger leukemia and lymphoma survivors.
Interventions
- OTHER questionnaire administration
- PROCEDURE psychosocial assessment and care
- PROCEDURE assessment of therapy complications
- PROCEDURE fatigue assessment and management
- BEHAVIORAL telephone-based intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2008-10 |
| Est. Completion | 2011-08 |
What the finished NCT00956475 record still lists
NCT00956475 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 48 participants, a relatively small participant target.
The record links to 0 conditions, and to 5 interventions - of which questionnaire administration is the first listed.
NCT00956475 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00956475 about?
NCT00956475 is a clinical study titled "Quality of Life in Younger Leukemia and Lymphoma Survivors". RATIONALE: Collecting information about the effect of hematologic cancer and its treatment on quality of life may help doctors learn more about the disease and plan the best treatment. PURPOSE: This phase I trial is studying quality of life in younger leukemia and lymphoma survivors.
What is the current status of trial NCT00956475?
This trial is currently completed. The enrollment target is 48 participants. The study started on 2008-10. Estimated completion is 2011-08.
What interventions are being tested in trial NCT00956475?
The interventions under investigation include: questionnaire administration (OTHER), psychosocial assessment and care (PROCEDURE), assessment of therapy complications (PROCEDURE), fatigue assessment and management (PROCEDURE), telephone-based intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00956475?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia